New Editorial Team Named for Progress in Cardiovascular Diseases
Henry Greenberg, MD named new Editor-in-Chief
New York, November 6, 2008 – Elsevier is honored to announce today that Henry Greenberg, MD, has been named the new Editor-in-Chief of Progress in Cardiovascular Diseases. Dr. Greenberg will be joined by Marrick L. Kukin, MD, and Franz H. Messerli, MD, as Editors. Dr. Greenberg takes over from the Journal’s former editors, the late Michael Lesch, MD, and the late Edmund H. Sonnenblick, MD.
Jane Grochowski, Elsevier Publisher for Progress in Cardiovascular Diseases, comments: “We are so pleased to welcome this outstanding new editorial team, who were colleagues of the late Dr. Lesch. We look forward to having them continue the venerable tradition of this well-respected journal.”
Dr. Greenberg is a leading researcher in clinical trials for various aspects of coronary disease and in the prevention of cardiovascular diseases in emerging economies. He has a long association with the New York Academy of Sciences, serving on the Board of Governors for many years and for one term as the board chairman. He currently chairs the Academy's Human Rights of Scientists Committee. Dr. Greenberg is Associate Director of Cardiology at St.Luke's-Roosevelt Hospital and Associate Professor of Clinical Medicine at Columbia University College of Physicians & Surgeons in New York City.
Dr. Kukin is Director of the Heart Failure Program at St. Lukes-Roosevelt Hospital Center and Professor of Clinical Medicine at the Columbia University College of Physicians & Surgeons in New York City. His areas of research include beta blockade and other neurohormonal antagonists in congestive heart failure and the use of inotropic agents in heart failure.
Dr. Messerli is an internationally recognized expert in hypertensive cardiovascular disease and preventive cardiology. He is Director of the Hypertension Program at St. Luke’s-Roosevelt Hospital and Professor of Clinical Medicine at Columbia University College of Physicians & Surgeons, Division of Cardiology, in New York City.
# # #
About Progress in Cardiovascular Diseases
Published bimonthly, Progress in Cardiovascular Diseases comprehensively covers single topics in the understanding and treatment of disorders of the heart and circulation. Many issues include special articles and definitive reviews that capture cutting-edge information in the management of cardiovascular diseases.
Elsevier is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com
+1 215 239 3652